Drug | Tablet
Gliclazide 80 mg
Type 2 diabetes mellitus (non-insulin-dependent) in adults, when diet and exercise alone are not sufficient; helps control blood glucose levels and reduce diabetes-related complications.
Gliclazide is a sulfonylurea that stimulates insulin release from pancreatic beta cells by closing ATP-sensitive potassium channels. This increases insulin secretion and helps lower blood glucose, mainly by improving post-meal and fasting glucose control.
Tablet for oral use. Take exactly as prescribed, usually once or twice daily with food (commonly with breakfast and/or evening meal) to reduce risk of hypoglycaemia. Swallow whole with water; do not skip meals. Regularly monitor blood glucose.
Common side effects of Reclide 80 Tablet may include:
May cause hypoglycaemia, especially with missed meals, excessive exercise, alcohol intake, or with other antidiabetic medicines; carry glucose/sugar source. Use with caution in elderly, malnourished patients, adrenal/pituitary insufficiency. Caution in renal or hepatic impairment; dose adjustment/alternative may be needed. Stop and seek care for severe allergy, jaundice, persistent abdominal pain, or signs of severe low sugar. Not indicated for type 1 diabetes or diabetic ketoacidosis. Inform doctor before surgery/acute illness as treatment may need adjustment.
